» Articles » PMID: 23298209

Mesenchymal Stem Cell: Keystone of the Hematopoietic Stem Cell Niche and a Stepping-stone for Regenerative Medicine

Overview
Date 2013 Jan 10
PMID 23298209
Citations 235
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) are self-renewing precursor cells that can differentiate into bone, fat, cartilage, and stromal cells of the bone marrow. Recent studies suggest that MSCs themselves are critical for forming a niche that maintains hematopoietic stem cells (HSCs). The ease by which human MSC-like and stromal progenitor cells can be isolated from the bone marrow and other tissues has led to the rapid development of clinical investigations exploring their anti-inflammatory properties, tissue preservation capabilities, and regenerative potential. However, the identity of genuine MSCs and their specific contributions to these various beneficial effects have remained enigmatic. In this article, we examine the definition of MSCs and discuss the importance of rigorously characterizing their stem cell activity. We review their role and that of other putative niche constituents in the regulation of bone marrow HSCs. Additionally, how MSCs and their stromal progeny alter immune function is discussed, as well as potential therapeutic implications.

Citing Articles

Establishment of iPSC-Derived MSCs Expressing hsa-miR-4662a-5p for Enhanced Immune Modulation in Graft-Versus-Host Disease (GVHD).

Lee S, Kim E, Lee H, Lim S, Jung C, Kang Y Int J Mol Sci. 2025; 26(2).

PMID: 39859561 PMC: 11766046. DOI: 10.3390/ijms26020847.


Challenges and Innovations in Alveolar Bone Regeneration: A Narrative Review on Materials, Techniques, Clinical Outcomes, and Future Directions.

Marian D, Toro G, DAmico G, Trotta M, DAmico M, Petre A Medicina (Kaunas). 2025; 61(1).

PMID: 39859003 PMC: 11766548. DOI: 10.3390/medicina61010020.


Advances in Stem Cell Therapy for Huntington's Disease: A Comprehensive Literature Review.

Shah S, Mansour H, Lucke-Wold B Cells. 2025; 14(1.

PMID: 39791743 PMC: 11719515. DOI: 10.3390/cells14010042.


Emerging insights into epigenetics and hematopoietic stem cell trafficking in age-related hematological malignancies.

Xinyi Y, Vladimirovich R, Beeraka N, Satyavathi A, Kamble D, Nikolenko V Stem Cell Res Ther. 2024; 15(1):401.

PMID: 39506818 PMC: 11539620. DOI: 10.1186/s13287-024-04008-4.


EPO modified MSCs protects SH-SY5Y cells against ischemia/hypoxia-induced apoptosis via REST-dependent epigenetic remodeling.

Jiang Y, Li R, Ban Y, Zhang W, Kong N, Tang J Sci Rep. 2024; 14(1):23252.

PMID: 39370424 PMC: 11456618. DOI: 10.1038/s41598-024-74261-3.